LLOYDS CLINICAL LIMITED

1. LLOYDS CLINICAL LIMITED 2024-11-18 → present
2. LLOYDS PHARMACY CLINICAL HOMECARE LIMITED 2016-10-13 → 2024-11-18
3. BUPA HOME HEALTHCARE LIMITED 2008-12-01 → 2016-10-13
4. CLINOVIA LIMITED 1999-06-15 → 2008-12-01
5. CAREMARK LIMITED 1993-02-10 → 1999-06-15
6. CAREMARK SERVICES LIMITED 1992-11-10 → 1993-02-10

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Auditor

BDO LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors concluded that they have a reasonable basis to support the going concern assertion for the financial statements. The Company has cash at bank and in hand of £1m, net current assets of £72m and net assets of £80m, demonstrating a strong financial position. In addition, the Company, as part of the Aurelius Elephant Limited group ("AEL Group"), refinanced the existing asset-backed loan ("ABL") facility in September 2025 for a minimum period of three years. Under the terms of the loan, certain eligible companies, including Lloyds Clinical Limited, can borrow up to £350m against eligible receivables (up from £275m). The debt financing is sufficient to enable the Company and its subsidiaries to continue as a going concern at least 12 months after issuance of these financial statements.”

Significant events

• “On 22nd May 2025, Lloyds Clinical Limited acquired the intellectual property to support its main brand from Admenta UK Limited for £32.6m”
• “On 22nd May 2025, the directors of Lloyds Clinical Limited approved the distribution of funds to the sole shareholder Admenta UK Limited amounting to £50m”
• “In September 2025, the Aurelius Elephant Limited group refinanced its existing asset-backed loan ("ABL") facility The revised facility, which has a minimum term of three years, increases the maximum borrowing capacity from £275m to £350m, secured against qualifying receivables of certain operating subsidiaries”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +5.4%

  £1,310,754,000 → £1,381,502,000

• Cash

  -58.6%

  £2,139,000 → £885,000

• Net assets

  +23.7%

  £64,654,000 → £79,981,000

• Employees

  +7.1%

  1,424 → 1,525

• Operating profit

  +214.3%

  £3,731,000 → £11,727,000

• Profit before tax

  +62.9%

  £13,503,000 → £21,997,000

• Wages

  +16.5%

  £48,327,000 → £56,285,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers